Bench Memos

Doing Nothing about ‘Cooked’ FDA Safety Standards Isn’t an Option

Share this story

A staff member at Alamo Women’s Clinic prepares Mifepristone, the first pill in a medical abortion, for a patient in Carbondale, Ill., April 9, 2024.

Evelyn Hockstein/Reuters

Recently, Michael Fragoso wrote in these pages that the Food and Drug Administration’s 2023 “safety standards” surrounding abortion drugs were “cooked by the left,” and that the FDA should halt the flood of unlawful abortion drugs across state lines. Indeed, that is why we are litigating Louisiana v. FDA — to provide such relief, despite Fragoso’s criticisms of the case.

It’s imperative to get the facts right. Our lawsuit isn’t a “coalition of states” case — it’s Louisiana defending its own sovereign laws against the Biden FDA’s reckless removal of in-person dispensing, alongside Rosalie Markezich, a young Louisiana woman whose ex-boyfriend ordered mifepristone from a California doctor, coerced her to take it, and ended the life of her child.

LM

About the Author

Liz Murrill

Liz Murrill is the attorney general of Louisiana.

KW

About the Author

Kristen Waggoner

Kristen Waggoner is CEO, president, and chief counsel of Alliance Defending Freedom.

Comments

Advertisement

Advertisement